Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study

Carboplatin administration can usually be safely continued via a so-called desensitisation protocol when hypersensitivity reactions arise. Severe break-through reactions that occur early during desensitisation are likely to be IgE-mediated; in that case, addition of omalizumab premedication should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Oude Elberink, Hanneke N. G., Jalving, Mathilde, Dijkstra, Hilda, van de Ven, Annick A. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990484/
https://www.ncbi.nlm.nih.gov/pubmed/32015827
http://dx.doi.org/10.1186/s13601-020-0309-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990484/
https://www.ncbi.nlm.nih.gov/pubmed/32015827
http://dx.doi.org/10.1186/s13601-020-0309-0

Ejemplares similares